2-73490794-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001378454.1(ALMS1):c.8835C>G(p.Asn2945Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0119 in 1,614,052 control chromosomes in the GnomAD database, including 159 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001378454.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00796 AC: 1211AN: 152162Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00876 AC: 2185AN: 249400Hom.: 17 AF XY: 0.00895 AC XY: 1211AN XY: 135324
GnomAD4 exome AF: 0.0123 AC: 17945AN: 1461772Hom.: 154 Cov.: 33 AF XY: 0.0122 AC XY: 8849AN XY: 727188
GnomAD4 genome AF: 0.00793 AC: 1208AN: 152280Hom.: 5 Cov.: 32 AF XY: 0.00722 AC XY: 538AN XY: 74464
ClinVar
Submissions by phenotype
not provided Benign:5
This variant is associated with the following publications: (PMID: 16720663, 25296579, 17594715) -
- -
ALMS1: BP4, BS1, BS2 -
- -
- -
not specified Benign:3
- -
- -
p.Asn2944Lys in exon 10 of ALMS1: This variant is not expected to have clinical significance because it has been identified in 1.38% (921/66738) of European chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs35062203). -
Alstrom syndrome Benign:2
- -
- -
Monogenic diabetes Benign:1
ACMG criteria: BP4 (9 predictors; Revel score 0.007), BS2 (18 homozygotes in gnomAD), BP1 (missense in gene with truncating mutations), BA1 (1.4% in European gnomAD; 1.1% in ESP); [InVitae, Partners & Childrens Mercy say benign but no longer using BP6]= benign -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at